Joint research activities with international impact
The Cologne/Bonn Ageing Cluster
The Max Planck Institute for Biology of Ageing is an integral part of a local life science cluster, with partner organisations that focus on research on ageing and ageing-related disease. Located on the campus of the University of Cologne and the Cologne Medical Centre, our institute serves as a link between the scientific communities in the Cologne/Bonn region, in Germany.
The local cluster is mainly composed by:
- Max Planck Institute for Metabolism Research (MPIMR)
- CECAD (University of Cologne Center for Excellence Cluster in Aging, Stress and Aging-Related Disease)
- DZNE (Helmholtz Center for Neurodegenerative Diseases)
- caesar Research Center
- The University of Cologne and its clinic
- The University of Bonn and its clinic
Besides local scientific collaborations, we also build a joint graduate programme to attract international top-students into our region by merging the IMPRS AGE with the CECAD Graduate School. Since 2013 our joint Cologne Graduate School of Ageing Research (CGA) has already attracted more than 30 young talents selected from more than 1000 applications. The CGA offers our excellent students a three-year, fully funded PhD fellowship with extensive training to develop their scientific career. Within the Cologne/Bonn Life Science Cluster our participating institutions, the Max Planck Institute for Biology of Ageing, the Max Planck Institute for Metabolism Research, the Center of Advanced European Studies and Research (caesar) as well as the University of Cologne build an outstanding infrastructure for the joint development of ageing research.
We are also part of the MaxNetAging Research School, which is under the umbrella of the Max Planck International Research Network on Aging (MaxNetAging). The aim of this network is to share knowledge across the disciplines about the challenges of an ageing society. The PhD students from the different research areas, such as political science, study of societies, medicine or biology stay the first half year of their PhD at the Max Planck Institute for Demographic research in Rostock. During this study they are introduced to the various aspects of ageing research.
Sharing expertise with scientists from around the world
We are looking forward to receive promising post-docs for further scientific maturation in our premises. We support candidates in applying to various fellowship programs to finance their stay in MPI for Biology of Ageing and enrich individual funding track records. Also established scientists are welcome to stay as guests for short stays or sabbaticals in MPI for Biology of Ageing. Applications should always be submitted to the departments of interest. The administration of MPI for Biology of Ageing is ready to guide you through application procedures and administrative requirements.
In addition, we host and co-organize international symposia, conferences and seminars all around the world and invite visiting scientists from the global scientific community to come and share their expertise in our regular in-house seminars.
If you are interested in working with us, you may also wish to take a look at our open positions. The Max Planck Institute for Biology of Ageing attracts scientists from around the world, and fosters their career development in a vibrant atmosphere with English as the working language. New ideas and creativity are crucial factors to shape our tomorrows success.
Building a bridge between basic and clinical research
We aim at linking our insights in basic science to the causes and processes underlying ageing-associated diseases, which affect a growing proportion of people in our ageing society. Cooperating with partners with clinical background like local university clinics or pharmaceutical companies allows us to bridge basic and clinical research, to establish and share common facilities and to foster translation for the benefit of our society. Our involvement in EIT (European Institute of Technology)- Health is an important step in this attempt and with great enthusiasm we became founding member of the EIT Health association in 2015. This public-private-partnership with more than 100 partners from industry and academia forms the largest ever collaboration in health-promoting initiatives in Europe and aims to speed the translation of research into clinical use and the entrepreneurial activities of young scientists (www.eit-health.eu). Nils-Göran Larsson, managing director of the Max-Planck-Institute for Biology of Ageing, has been selected as board member of EIT Health e.V. for its constituting period from 2015-2017.